Collegium Pharmaceutical

Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing proprietary, late-stage products that address non-medical use and abuse of prescription drugs through tamper-resistant formulations and extended-release delivery using its patent-protected DETERx platform. The company markets Xtampza ER, an abuse-deterrent extended-release oxycodone, and Nucynta products, including extended-release and immediate-release formulations of tapentadol for long- and short-term pain management. Its portfolio also includes Jornay as part of its product lineup, reflecting a strategy to expand applications of the DETERx technology. Headquartered in Stoughton, Massachusetts.

Joseph Ciaffoni

CEO and President

2 past transactions

Ironshore Pharmaceuticals

Acquisition in 2024
Ironshore Pharmaceuticals Inc. is a pharmaceutical company whose mission is to develop and commercialize first-in-class treatment options to improve the lives of patients and caregivers.

BioDelivery Sciences International

Acquisition in 2022
BioDelivery Sciences International, Inc. is a specialty pharmaceutical company headquartered in Raleigh, North Carolina, dedicated to addressing the needs of patients with chronic pain and opioid dependence. Founded in 1997, the company focuses on the development and commercialization of innovative pharmaceutical products, leveraging its proprietary BioErodible MucoAdhesive (BEMA) drug-delivery technology. This technology allows for the creation of small erodible polymer films designed for effective application to the buccal mucosa. BioDelivery Sciences offers a range of products, including BELBUCA, a buprenorphine buccal film for chronic pain management, and BUNAVAIL, a buprenorphine and naloxone buccal film aimed at treating opioid dependence. Additionally, it provides ONSOLIS, a fentanyl buccal soluble film for managing breakthrough pain in cancer patients, and Symproic, which treats opioid-induced constipation in adults with chronic pain. The company's focus on novel drug delivery methods enables it to address important unmet medical needs in pain management and addiction medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.